Agouti-related peptide and MC3/4 receptor agonists both inhibit excitatory hypothalamic ventromedial nucleus neurons

Journal of Neuroscience

Volumn 28, Issue 21, 2008, Pages 5433-5449

  Fu, Li Ying ^a   Van Den Pol, Anthony N ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arcuate nucleus; Feeding; Glutamate; NPY; POMC; vGluT2

Indexed keywords

AGOUTI RELATED PROTEIN; ALPHA INTERMEDIN; GLUTAMIC ACID; GREEN FLUORESCENT PROTEIN; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 3 RECEPTOR AGONIST; MELANOCORTIN 4 RECEPTOR; MELANOCORTIN 4 RECEPTOR AGONIST; MELANOCORTIN RECEPTOR 3 ANTAGONIST; MELANOCORTIN RECEPTOR 4 ANTAGONIST; MELANOTAN II; N ACETYL ALPHA INTERMEDIN[4-10]CYCLO[4 NORLEUCINE 5 ASPARTIC ACID 7 [3 (2 NAPHTHYL)ALANINE] 10 LYSINAMIDE]; NF 023; PERTUSSIS TOXIN; UNCLASSIFIED DRUG; VESICULAR GLUTAMATE TRANSPORTER 2; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ACETYL NORLEUCYL(4) (ASPARTYL(5) HISTIDYL(6) PHENYLALANYL(7) ARGINYL(8) TRYPTOPHYL(9) LYSYL(10))CYCLO ALPHA MSH(4 10)AMIDE; ACETYL-NORLEUCYL(4)-(ASPARTYL(5)-HISTIDYL(6)-PHENYLALANYL(7)-ARGINYL(8)-TRYPTOPHYL(9)-LYSYL(10))CYCLO-ALPHA-MSH(4-10)AMIDE; AMINO ACID RECEPTOR BLOCKING AGENT; AMINO ACID RECEPTOR STIMULATING AGENT; DRUG DERIVATIVE; GLUCOSE TRANSPORTER 2; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 1; INTERMEDIN; MUSCIMOL; NEUROPEPTIDE Y; SLC17A6 PROTEIN, MOUSE; SLC2A2 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; DENDRITE; DRUG RECEPTOR BINDING; HYPERPOLARIZATION; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; IMMUNOCOMPETENT CELL; MOUSE; NERVE CELL EXCITABILITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; PROMOTER REGION; ANALYSIS OF VARIANCE; ANIMAL; BIOSYNTHESIS; CELL MEMBRANE POTENTIAL; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; ELECTROSTIMULATION; GENETICS; IN VITRO STUDY; METABOLISM; METHODOLOGY; NERVE CELL; NERVE CELL INHIBITION; NERVE FIBER; PATCH CLAMP; PHYSIOLOGY; RADIATION EXPOSURE; RADIATION RESPONSE; TRANSGENIC MOUSE;

AGOUTI-RELATED PROTEIN; ALPHA-MSH; ANALYSIS OF VARIANCE; ANIMALS; AXONS; DOSE-RESPONSE RELATIONSHIP, RADIATION; ELECTRIC STIMULATION; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; GABA AGONISTS; GLUCOSE TRANSPORTER TYPE 2; GLUTAMATE DECARBOXYLASE; GREEN FLUORESCENT PROTEINS; MELANOCYTE-STIMULATING HORMONES; MEMBRANE POTENTIALS; MICE; MICE, TRANSGENIC; MUSCIMOL; NEURAL INHIBITION; NEURONS; NEUROPEPTIDE Y; PATCH-CLAMP TECHNIQUES; RECEPTOR, MELANOCORTIN, TYPE 3; VENTROMEDIAL HYPOTHALAMIC NUCLEUS; VESICULAR GLUTAMATE TRANSPORT PROTEIN 2;

EID: 45849130547     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0749-08.2008     Document Type: Article

References (99)

1. Acuna-Goycolea C, Tamamaki N, Yanagawa Y, Obata K, van den Pol AN (2005) Mechanisms of neuropeptide Y, peptide YY, and pancreatic polypeptide inhibition of identified green fluorescent protein-expressing GABA neurons in the hypothalamic neuroendocrine arcuate nucleus. J Neurosci 25:7406-7419.
2. Beart PM, Nicolopoulos LS, West DC, Headley PM (1988) An excitatory amino acid projection from ventromedial hypothalamus to periaqueductal gray in the rat: autoradiographic and electrophysiological evidence. Neurosci Lett 85:205-211.
3. Bednarek MA, MacNeil T, Tang R, Kalyani RN, Van der Ploeg LH, Weinberg DH (2001) Potent and selective peptide agonists of alpha-melanotropin action at human melanocortin receptor 4: their synthesis and biological evaluation in vitro. Biochem Biophys Res Commun 286:641-645.
4. Beindl W, Mitterauer T, Hohenegger M, Ijzerman AP, Nanoff C, Freissmuth M (1996) Inhibition of receptor/G protein coupling by suramin analogues. Mol Pharmacol 50:415-423.
5. Bekkers JM, Stevens CF (1995) Quantal analysis of EPSCs recorded from small numbers of synapses in hippocampal cultures. J Neurophysiol 73:1145-1156.
6. Bellasio S, Nicolussi E, Bertorelli R, Reggiani A (2003) Melanocortin receptor agonists and antagonists modulate nociceptive sensitivity in the mouse formalin test. Eur J Pharmacol 482:127-132.
7. Benoit SC, Air EL, Coolen LM, Strauss R, Jackman A, Clegg DJ, Seeley RJ, Woods SC (2002) The catabolic action of insulin in the brain is mediated by melanocortins. J Neurosci 22:9048-9052.
8. Bewick GA, Gardiner JV, Dhillo WS, Kent AS, White NE, Webster Z, Ghatei MA, Bloom SR (2005) Post-embryonic ablation of AgRP neurons in mice leads to a lean, hypophagic phenotype. FASEB J 19:1680-1682.
9. D-aspartate receptors. Neuroendocrinology 62:187-197.
10. Boden P, Hill RG (1988) Effects of cholecystokinin and related peptides on neuronal activity in the ventromedial nucleus of the rat hypothalamus. Br J Pharmacol 94:246-252.
11. Brobeck JR (1946) Mechanism of the development of obesity in animals with hypothalamic lesions. Physiol Rev 26:541-559.
12. Broberger C, Johansen J, Johansson C, Schalling M, Hokfelt T (1998) The neuropeptide Y/agouti gene-related protein (AgRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proc Natl Acad Sci USA 95:15043-15048.
13. Brown KS, Gentry RM, Rowland NE (1998) Central injection in rats of alpha-melanocyte-stimulating hormone analog: effects on food intake and brain Fos. Regul Pept 78:89-94.
14. Butler AA, Cone RD (2002) The melanocortin receptors: lessons from knockout models. Neuropeptides 36:77-84.
15. Butler AA, Kesterson RA, Khong K, Cullen MJ, Pelleymounter MA, Dekoning J, Baetscher M, Cone RD (2000) A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 141:3518-3521.
16. Chai BX, Neubig RR, Millhauser GL, Thompson DA, Jackson PJ, Barsh GS, Dickinson CJ, Li JY, Lai YM, Gantz I (2003) Inverse agonist activity of agouti and agouti-related protein. Peptides 24:603-609.
17. Chaki S, Okuyama S (2005) Involvement of melanocortin-4 receptor in anxiety and depression. Peptides 26:1952-1964.
18. Chaki S, Oshida Y, Ogawa S, Funakoshi T, Shimazaki T, Okubo T, Nakazato A, Okuyama S (2005) MCL0042: a nonpeptidic MC4 receptor antagonist and serotonin reuptake inhibitor with anxiolytic- and antidepressant-like activity. Pharmacol Biochem Behav 82:621-626.
19. Chen AS, Metzger JM, Trumbauer ME, Guan XM, Yu H, Frazier EG, Marsh DJ, Forrest MJ, Gopal-Truter S, Fisher J, Camacho RE, Strack AM, Mellin TN, MacIntyre DE, Chen HY, Van der Ploeg LH (2000a) Role of the melanocortin-4 receptor in metabolic rate and food intake in mice. Transgenic Res 9:145-154.
20. Chen AS, Marsh DJ, Trumbauer ME, Frazier EG, Guan XM, Yu H, Rosenblum CI, Vongs A, Feng Y, Cao L, Metzger JM, Strack AM, Camacho RE, Mellin TN, Nunes CN, Min W, Fisher J, Gopal-Truter S, MacIntyre DE, Chen HY, et al. (2000b) Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat Genet 26:97-102.
21. Chen HY, Trumbauer ME, Chen AS, Weingarth DT, Adams JR, Frazier EG, Shen Z, Marsh DJ, Feighner SD, Guan XM, Ye Z, Nargund RP, Smith RG, Van der Ploeg LH, Howard AD, MacNeil DJ, Qian S (2004) Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein. Endocrinology 145:2607-2612.
22. Choudhury AI, Heffron H, Smith MA, Al-Qassab H, Xu AW, Selman C, Simmgen M, Clements M, Claret M, Maccoll G, Bedford DC, Hisadome K, Diakonov I, Moosajee V, Bell JD, Speakman JR, Batterham RL, Barsh GS, Ashford ML, Withers DJ (2005) The role of insulin receptor substrate 2 in hypothalamic and beta cell function. J Clin Invest 115:940-950.
23. Collin M, Backberg M, Ovesjo ML, Fisone G, Edwards RH, Fujiyama F, Meister B (2003) Plasma membrane and vesicular glutamate transporter mRNAs/proteins in hypothalamic neurons that regulate body weight. Eur J Neurosci 18:1265-1278.
24. Commons KG, Kow LM, Milner TA, Pfaff DW (1999) In the ventromedial nucleus of the rat hypothalamus, GABA-immunolabeled neurons are abundant and are innervated by both enkephalin- and GABA-immunolabeled axon terminals. Brain Res 816:58-67.
25. Cone RD (1999) The central melanocortin system and energy homeostasis. Trends Endocrinol Metab 10:211-216.
26. Cone RD (2005) Anatomy and regulation of the central melanocortin system. Nat Neurosci 8:571-578.
27. Cone RD, Lu D, Koppula S, Vage DI, Klungland H, Boston B, Chen W, Orth DN, Pouton C, Kesterson RA (1996) The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation. Recent Prog Horm Res 51:287-317.
28. Cowley MA, Pronchuk N, Fan W, Dinulescu DM, Colmers WF, Cone RD (1999) Integration of NPY, AgRP, and melanocortin signals in the hypothalamic paraventricular nucleus: evidence of a cellular basis for the adipostat. Neuron 24:155-163.
29. Cowley MA, Smart JL, Rubinstein M, Cerdan MG, Diano S, Horvath TL, Cone RD, Low MJ (2001) Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411:480-484.
30. Davidowa H, Li Y, Plagemann A (2002) Differential response to NPY of PVH and dopamine-responsive VMH neurons in overweight rats. NeuroReport 13:1523-1527.
31. Davidowa H, Li Y, Plagemann A (2003) Altered responses to orexigenic (AGRP, MCH) and anorexigenic (alpha-MSH, CART) neuropeptides of paraventricular hypothalamic neurons in early postnatally overfed rats. Eur J Neurosci 18:613-621.
32. +-channels in LTD. Eur J Neurosci 17:1411-1424.
33. Dhillon H, Zigman JM, Ye C, Lee CE, McGovern RA, Tang V, Kenny CD, Christiansen LM, White RD, Edelstein EA, Coppari R, Balthasar N, Cowley MA, Chua Jr S, Elmquist JK, Lowell BB (2006) Leptin directly activates SF1 neurons in the VMH, and this action by leptin is required for normal body-weight homeostasis. Neuron 49:191-203.
34. Elias CF, Aschkenasi C, Lee C, Kelly J, Ahima RS, Bjorbaek C, Flier JS, Saper CB, Elmquist JK (1999) Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area. Neuron 23:775-786.
35. Elmquist JK, Elias CF, Saper CB (1999) From lesions to leptin: hypothalamic control of food intake and body weight. Neuron 22:221-232.
36. Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD (1997) Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385:165-168.
37. Farooqi IS, Yeo GS, Keogh JM, Aminian S, Jebb SA, Butler G, Cheetham T, O'Rahilly S (2000) Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J Clin Invest 106:271-279.
38. Fong TM, Mao C, MacNeil T, Kalyani R, Smith T, Weinberg D, Tota MR, Van der Ploeg LH (1997) ART (protein product of agouti-related transcript) as an antagonist of MC-3 and MC-4 receptors. Biochem Biophys Res Commun 237:629-631.
39. Freissmuth M, Boehm S, Beindl W, Nickel P, Ijzerman AP, Hohenegger M, Nanoff C (1996) Suramin analogues as subtype-selective G protein inhibitors. Mol Pharmacol 49:602-611.
40. Fremeau Jr RT, Troyer MD, Pahner I, Nygaard GO, Tran CH, Reimer RJ, Bellocchio EE, Fortin D, Storm-Mathisen J, Edwards RH (2001) The expression of vesicular glutamate transporters defines two classes of excitatory synapse. Neuron 31:247-260.
41. Fremeau Jr RT, Kam K, Qureshi T, Johnson J, Copenhagen DR, Storm-Mathisen J, Chaudhry FA, Nicoll RA, Edwards RH (2004) Vesicular glutamate transporters 1 and 2 target to functionally distinct synaptic release sites. Science 304:1815-1819.
42. Fu LY, Acuna-Goycolea C, van den Pol AN (2004) Neuropeptide Y inhibits hypocretin/orexin neurons by multiple presynaptic and postsynaptic mechanisms: tonic depression of the hypothalamic arousal system. J Neurosci 24:8741-8751.
43. Gao XB, van den Pol AN (1999) Neurotrophin-3 potentiates excitatory GABAergic synaptic transmission in cultured developing hypothalamic neurones of the rat. J Physiol (Lond) 518:81-95.
44. 2+ transient. Alcohol Clin Exp Res 29:1237-1246.
45. Gee CE, Chen CL, Roberts JL, Thompson R, Watson SJ (1983) Identification of proopiomelanocortin neurones in rat hypothalamus by in situ cDNA-mRNA hybridization. Nature 306:374-376.
46. Gonzalez MI, Vaziri S, Wilson CA (1996) Behavioral effects of alpha-MSH and MCH after central administration in the female rat. Peptides 17:171-177.
47. Grieco P, Balse PM, Weinberg D, MacNeil T, Hruby VJ (2000) D-Amino acid scan of gamma-melanocyte-stimulating hormone: importance of Trp(8) on human MC3 receptor selectivity. J Med Chem 43:4998-5002.
48. Gropp E, Shanabrough M, Borok E, Xu AW, Janoschek R, Buch T, Plum L, Balthasar N, Hampel B, Waisman A, Barsh GS, Horvath TL, Bruning JC (2005) Agouti-related peptide-expressing neurons are mandatory for feeding. Nat Neurosci 8:1289-1291.
49. Hahn TM, Breininger JF, Baskin DG, Schwartz MW (1998) Coexpression of AgRP and NPY in fasting-activated hypothalamic neurons. Nat Neurosci 1:271-272.
50. Harrold JA, Williams G (2006) Melanocortin-4 receptors, beta-MSH and leptin: key elements in the satiety pathway. Peptides 27:365-371.
51. Harrold JA, Widdowson PS, Williams G (1999) Altered energy balance causes selective changes in melanocortin-4 (MC4-R), but not melanocortin-3 (MC3-R), receptors in specific hypothalamic regions: further evidence that activation of MC4-R is a physiological inhibitor of feeding. Diabetes 48:267-271.
52. Haskell-Luevano C, Monck EK (2001) Agouti-related protein functions as an inverse agonist at a constitutively active brain melanocortin-4 receptor. Regul Pept 99:1-7.
53. Haskell-Luevano C, Chen P, Li C, Chang K, Smith MS, Cameron JL, Cone RD (1999) Characterization of the neuroanatomical distribution of agouti-related protein immunoreactivity in the rhesus monkey and the rat. Endocrinology 140:1408-1415.
54. Hettes SR, Gonzaga J, Heyming TW, Perez S, Wolfsohn S, Stanley BG (2003) Dual roles in feeding for AMPA/kainate receptors: receptor activation or inactivation within distinct hypothalamic regions elicits feeding behavior. Brain Res 992:167-178.
55. Hillebrand JJ, Kas MJ, Adan RA (2005) α-MSH enhances activity-based anorexia. Peptides 26:1690-1696.
56. Hirrlinger J, Moeller H, Kirchhoff F, Dringen R (2005) Expression of multidrug resistance proteins (Mrps) in astrocytes of the mouse brain: a single cell RT-PCR study. Neurochem Res 30:1237-1244.
57. 2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors. J Med Chem 38:3454-3461.
58. Huang H, Ghosh P, van den Pol AN (2006) Prefrontal cortex-projecting glutamatergic thalamic paraventricular nucleus-excited by hypocretin: a feedforward circuit that may enhance cognitive arousal. J Neurophysiol 95:1656-1668.
59. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F (1997) Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88:131-141.
60. Jegou S, Boutelet I, Vaudry H (2000) Melanocortin-3 receptor mRNA expression in pro-opiomelanocortin neurones of the rat arcuate nucleus. J Neuroendocrinol 12:501-505.
61. Jonsson L, Skarphedinsson JO, Skuladottir GV, Watanobe H, Schioth HB (2002) Food conversion is transiently affected during 4-week chronic administration of melanocortin agonist and antagonist in rats. J Endocrinol 173:517-523.
62. Kang L, Routh VH, Kuzhikandathil EV, Gaspers LD, Levin BE (2004) Physiological and molecular characteristics of rat hypothalamic ventromedial nucleus glucosensing neurons. Diabetes 53:549-559.
63. Kawashima N, Chaki S, Okuyama S (2003) Electrophysiological effects of melanocortin receptor ligands on neuronal activities of monoaminergic neurons in rats. Neurosci Lett 353:119-122.
64. Keesey RE, Powley TL (1986) The regulation of body weight. Annu Rev Psychol 37:109-133.
65. King BM (2006) The rise, fall, and resurrection of the ventromedial hypothalamus in the regulation of feeding behavior and body weight. Physiol Behav 87:221-244.
66. Kishi T, Aschkenasi CJ, Lee CE, Mountjoy KG, Saper CB, Elmquist JK (2003) Expression of melanocortin 4 receptor mRNA in the central nervous system of the rat. J Comp Neurol 457:213-235.
67. Kishi T, Aschkenasi CJ, Choi BJ, Lopez ME, Lee CE, Liu H, Hollenberg AN, Friedman JM, Elmquist JK (2005) Neuropeptide Y Y1 receptor mRNA in rodent brain: distribution and colocalization with melanocortin-4 receptor. J Comp Neurol 482:217-243.
68. Konda Y, Gantz I, Del Valle J, Shimoto Y, Miwa H, Yamada T (1994) Interaction of dual intracellular signaling pathways activated by the melanocortin-3 receptor. J Biol Chem 269:13162-13166.
69. Lee EJ, Lee SH, Jung JW, Lee W, Kim BJ, Park KW, Lim SK, Yoon CJ, Baik JH (2001) Differential regulation of cAMP-mediated gene transcription and ligand selectivity by MC3R and MC4R melanocortin receptors. Eur J Biochem 268:582-591.
70. Lee SW, Stanley BG (2005) NMDA receptors mediate feeding elicited by neuropeptide Y in the lateral and perifornical hypothalamus. Brain Res 1063:1-8.
71. Li YZ, Davidowa H (2004) Food deprivation decreases responsiveness of ventromedial hypothalamic neurons to melanocortins. J Neurosci Res 77:596-602.
72. Lin S, Boey D, Lee N, Schwarzer C, Sainsbury A, Herzog H (2006) Distribution of prodynorphin mRNA and its interaction with the NPY system in the mouse brain. Neuropeptides 40:115-123.
73. Liss B, Bruns R, Roeper J (1999) Alternative sulfonylurea receptor expression defines metabolic sensitivity of K-ATP channels in dopaminergic midbrain neurons. EMBO J 18:833-846.
74. Liu H, Kishi T, Roseberry AG, Cai X, Lee CE, Montez JM, Friedman JM, Elmquist JK (2003) Transgenic mice expressing green fluorescent protein under the control of the melanocortin-4 receptor promoter. J Neurosci 23:7143-7154.
75. Luquet S, Perez FA, Hnasko TS, Palmiter RD (2005) NPY/AgRP neurons are essential for feeding in adult mice but can be ablated in neonates. Science 310:683-685.
76. Marks DL, Cone RD (2003) The role of the melanocortin-3 receptor in cachexia. Ann NY Acad Sci 994:258-266.
77. Marsh DJ, Miura GI, Yagaloff KA, Schwartz MW, Barsh GS, Palmiter RD (1999) Effects of neuropeptide Y deficiency on hypothalamic agouti-related protein expression and responsiveness to melanocortin analogues. Brain Res 848:66-77.
78. Millhouse OE (1973a) The organization of the ventromedial hypothalamic nucleus. Brain Res 55:71-87.
79. Millhouse OE (1973b) Certain ventromedial hypothalamic afferents. Brain Res 55:89-105.
80. Minami T, Oomura Y, Sugimori M (1986) Electrophysiological properties and glucose responsiveness of guinea-pig ventromedial hypothalamic neurones in vitro. J Physiol (Lond) 380:127-143.
81. Nijenhuis WA, Oosterom J, Adan RA (2001) AgRP(83-132) acts as an inverse agonist on the human-melanocortin-4 receptor. Mol Endocrinol 15:164-171.
82. Ollmann MM, Wilson BD, Yang YK, Kerns JA, Chen Y, Gantz I, Barsh GS (1997) Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278:135-138.
83. Poggioli R, Vergoni AV, Bertolini A (1986) ACTH-(1-24) and alpha-MSH antagonize feeding behavior stimulated by kappa opiate agonists. Peptides 7:843-848.
84. Priestley T (1992) The effect of baclofen and somatostatin on neuronal activity in the rat ventromedial hypothalamic nucleus in vitro. Neuropharmacology 31:103-109.
85. Pritchard LE, White A (2005) Agouti-related protein: more than a melanocortin-4 receptor antagonist? Peptides 26:1759-1770.
86. Roselli-Rehfuss L, Mountjoy KG, Robbins LS, Mortrud MT, Low MJ, Tatro JB, Entwistle ML, Simerly RB, Cone RD (1993) Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc Natl Acad Sci USA 90:8856-8860.
87. Rossi M, Kim MS, Morgan DG, Small CJ, Edwards CM, Sunter D, Abusnana S, Goldstone AP, Russell SH, Stanley SA, Smith DM, Yagaloff K, Ghatei MA, Bloom SR (1998) A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo. Endocrinology 139:4428-4431.
88. Schwartz MW, Woods SC, Porte Jr D, Seeley RJ, Baskin DG (2000) Central nervous system control of food intake. Nature 404:661-671.
89. Slamberova R, Hnatczuk OC, Vathy I (2004) Expression of proopiomelanocortin and proenkephalin mRNA in sexually dimorphic brain regions are altered in adult male and female rats treated prenatally with morphine. J Pept Res 63:399-408.
90. Smith AI, Funder JW (1988) Proopiomelanocortin processing in the pituitary, central nervous system, and peripheral tissues. Endocr Rev 9:159-179.
91. Smith MA, Hisadome K, Al-Qassab H, Heffron H, Withers DJ, Ashford ML (2007) Melanocortins and agouti-related protein modulate the excitability of two arcuate nucleus neuron populations by alteration of resting potassium conductances. J Physiol (Lond) 578:425-438.
92. Srinivasan S, Vaisse C, Conklin BR (2003) Engineering the melanocortin-4 receptor to control G(s) signaling in vivo. Ann NY Acad Sci 994:225-232.
93. Stellar E (1954) The physiology of motivation. Psychol Rev 61:5-22.
94. Sternson SM, Shepherd GM, Friedman JM (2005) Topographic mapping of VMH → arcuate nucleus microcircuits and their reorganization by fasting. Nat Neurosci 8:1356-1363.
95. 2+ channel types coexist to regulate synaptosomal neurotransmitter release. Proc Natl Acad Sci USA 90:9518-9522.
96. Vaisse C, Clement K, Durand E, Hercberg S, Guy-Grand B, Froguel P (2000) Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest 106:253-262.
97. van den Pol AN, Wuarin JP, Dudek FE (1990) Glutamate, the dominant excitatory transmitter in neuroendocrine regulation. Science 250:1276-1278.
98. Yaswen L, Diehl N, Brennan MB, Hochgeschwender U (1999) Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat Med 5:1066-1070.
99. Ziegler DR, Cullinan WE, Herman JP (2002) Distribution of vesicular glutamate transporter mRNA in rat hypothalamus. J Comp Neurol 448:217-229.